The results showed that the combination more strongly reduced c-FLIPL and c-FLIPs (Fig 3) levels than either of the drugs alone, indicating that c-FLIP does have a role in the synergy attained between the two drugs in choroidal melanoma cells. The gene discussed is CFLAR; the disease is choroidal melanoma.